Antipodes Partners LTD Alcon Inc Transaction History
Antipodes Partners LTD
- $2.85 Billion
- Q4 2024
A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,145,362 shares of ALC stock, worth $103 Million. This represents 3.42% of its overall portfolio holdings.
Number of Shares
1,145,362
Previous 1,076,360
6.41%
Holding current value
$103 Million
Previous $108 Million
9.73%
% of portfolio
3.42%
Previous 3.81%
Shares
2 transactions
Others Institutions Holding ALC
# of Institutions
741Shares Held
260MCall Options Held
2.02MPut Options Held
2.92M-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.75 Billion0.03% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.38 Billion1.27% of portfolio
-
Norges Bank Oslo, Q812.6MShares$1.13 Billion0.15% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL12MShares$1.07 Billion0.24% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.8MShares$1.06 Billion2.04% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $43.9B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...